Tsipi Keren-Lehrer has served as our Head of BD and Strategic Advisor since August 2019. Tsipi also serves as mentor for young startups via both SPARK at Tel-Aviv University and the Biomed-MBA program at the Hebrew University. Prior to joining the company, from August 2001 to June 2018, she served at Compugen with growing responsibilities until assuming the BD leadership and joining the company’s executive management in 2012 as VP of Business Development. She led multiple partnering efforts including the transformative transaction with Bayer HealthCare with over USD $550 million total deal value, and played an important role in the company's strategic focus shift towards drug development in cancer immunotherapy. Ms. Keren-Lehrer holds a BSc in Biology (cum laude) and an LL.B., both from Tel-Aviv University, and she is a certified lawyer in Israel.